Biblio

Author Title [ Type

] Year

Filters: Author is Peng, Jun [Clear All Filters]

Journal Article

Hua M, Li J, Wang C, Shao L, Hou M, Peng J, Feng Q. Aberrant expression of microRNA in CD4 cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia. Thromb Res. 2019;177:70-78.

Huang Q-S, Liu Y, Wang J-B, Peng J, Hou M, Liu H, Feng R, Wang J-W, Xu L-P, Wang Y, et al. All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet Haematol. 2021;8(10):e688-e699.

Xie X, Chen J, Wo D, Ma E, Ning Y, Peng J, Zhu W, Ren D-N. Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemness. J Ethnopharmacol. 2021:114449.

Pei Y, Peng J, Behl M, Sipes NS, Shockley KR, Rao MS, Tice RR, Zeng X. Comparative neurotoxicity screening in Human iPSC-derived neural stem Cells, Neurons and Astrocytes. Brain Res. 2015.

Peng J, Liu B, Ma Q-L, Luo X-J. Dysfunctional endothelial progenitor cells in cardiovascular diseases: role of NADPH oxidase. J Cardiovasc Pharmacol. 2014.

Wang Y, Zhang J, Su Y, Wang C, Zhang G, Liu X, Chen Q, Lv M, Chang Y, Peng J, et al. miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K/Akt and p53 in Immune Thrombocytopenia. Mol Ther Nucleic Acids. 2020;20:764-776.

Wu Y-J, Hou M, Liu H-X, Peng J, Ma L-M, Yang L-H, Feng R, Liu H, Liu Y, Feng J, et al. A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data. Blood Adv. 2020;4(22):5846-5857.

Zhao P, Hou M, Liu Y, Liu H-X, Bin Huang R-, Yao H-X, Niu T, Peng J, Jiang M, Han Y-Q, et al. Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age. Platelets. 2020:1-9.

Sun S, Gao N, Hu X, Luo H, Peng J, Xia Y. SOD3 overexpression alleviates cerebral ischemia-reperfusion injury in rats. Mol Genet Genomic Med. 2019:e831.

Ma J, Ning Y-N, Xu M, Hou Y, Wang N, Hou X-Y, Yu Y-Y, Li H, He W-D, Shao L-L, et al. Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia. Blood. 2013.

Wu X, Qin K, Wang D, Xiang K, Peng J, Guo J, Yang J, Fan C. Ultrasound-guided Induced Pluripotent Stem Cell-derived Cardiomyocyte Implantation in Myocardial Infarcted Mice. J Vis Exp. 2022;(181).